Global Discussions

Making connections and conversations

As a biopharmaceutical company that currently develops technologies called ‘antibiotic resistance breakers’ (combining existing antibiotic treatments to create bacterial resistant analogues), we created a programme which engaged medical, research and investment communities in conversations about the global antibiotic resistance crisis.

More Digital

A targeted social media campaign launched around an influential global industry conference resulted in our content being viewed over 25,000 times. Subsequently, media features were placed with Reuters, AP News, BBC and CNBC promoting the technology as a potential next candidate to fight the inevitable threat to modern medicine posed by global antibacterial infections.